Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: October 11, 2024 4:45 P.M.
Form: S-4
CIK: 0001541157
Company Name: Akari Therapeutics Plc
File Number: 333-282127